Stacy Finkbeiner, PhD

North America Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., Parsippany, New Jersey

JCP
Impact of Tardive Dyskinesia on Patient Lives
Original Research

April 3, 2023

This survey reveals the substantial burden of tardive dyskinesia on people’s lives and on the management of their underlying condition.
Rakesh Jain, Rajeev Ayyagari, Debbie Goldschmidt, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe